FMO5 and Hypertension: Our present study aimed to detail the effects of CD40L-CD40-TRAF6 signaling in hypertensive mice using a CD40-TRAF6 small molecule inhibitor in a model of arterial hypertension with a key role for reactive oxygen species formation by phagocytic NADPH oxidase [[12], [13], [14]].